Deal includes a number of radioligand therapies targeting solid tumors, such as breast, prostate, and lung cancers.
Novartis Set to Acquire Mariana Oncology to Enhance Radioligand Therapy Pipeline
Posted on by admin
1 min read
+ There are no comments
Add yours